Stockreport

Aprea Therapeutics, Inc. (APRE) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]

Aprea Therapeutics, Inc.  (APRE) 
PDF This compares to loss of $0.86 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.67 [Read more]